ÔçÒÒŮѸÀ×

    • <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      
    

    

      Rocket Pharmaceuticals Inc
      Rocket Pharmaceuticals Inc
      RCKT
      Market Cap$353.93M
       Close$
      
      
      
      
      Compare to Similar Companies
      P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
      Rocket Pharmaceuticals IncRocket Pharmaceuticals Inc-1.4--73%-0.1
      $2.25
      Target Price by Analysts
      30.3% downsideRocket Pharmaceuticals Target Price DetailsTarget Price
      $1.46
      Current Fair Value
      54.9% downside
      Overvalued by 54.9% based on the discounted cash flow analysis.
      Share Statistics
      Market cap$353.93 Million
      Enterprise Value$346.31 Million 
      Dividend Yield$- (-)
      Earnings per Share$-2.73 
      Beta0.65
      Outstanding Shares111,019,647
      Return
      Return on Equity-
      Return on Assets-
      Return on Invested Capital-
      Valuation & Multiples
      P/E Ratio-1.42
      PEG135.58
      Price to Sales-
      Price to Book Ratio1.08
      Enterprise Value to Revenue-
      Enterprise Value to EBIT-1.34
      Enterprise Value to Net Income-2
      Total Debt to Enterprise0.07
      Debt to Equity0.07
      Revenue Sources
      No data
      Insider Trades
      ESG Score
      No data
      About Rocket Pharmaceuticals Inc
      151 employees
      CEO: Gaurav Shah 
      
      
      


    
      
  
      
    

    
  
      

      

    
      
  To improve your user experience we use
  cookies.
  

      

    
  
  
      
  
      

  
  

  

  
  

  
HoMEÔçÒÒŮѸÀ×